Sunitinib malate is one of the multitargeted tyrosine kinase inhibitor, which are being used in clinic.It can inhibit more than 80 kinds of receptor`s tyrosine
Objective: This phase II study aimed at investigating the correlation between O6-methylguanine-DNA methyl-transferase (MGMT) promoter methylation and protein ex